Previous 10 | Next 10 |
Are These On Your List Of Penny Stocks To Buy Right Now? Everyone knows penny stocks can be risky. But with that higher risk comes the potential for higher rewards. Sure penny stocks under $0.50 that jump a quarter or more bring some big wins and great excitement to traders. How about t...
Medically Trained Senior Executive/Board Member with Extensive Experience in Clinical Research and Drug Development Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing novel cell transplants for serious medica...
Shares of clinical-stage biotech Lineage Cell Therapeutics (NYSEMKT: LCTX) rose sharply on Tuesday after the company announced a worldwide license agreement with privately held biotech Immunomic Therapeutics. Lineage Cell Therapeutics' stock rose as much as 10.6% but closed the day ...
Lineage Cell Therapeutics (LCTX) inks worldwide license and development collaboration agreement with Immunomic Therapeutics to develop a treatment for glioblastoma multiforme ((GBM)), a devastating brain cancer that typically results in death in the first 15 months after d...
Lineage to Receive $2 Million Upfront and up to $67 Million in Development and Commercial Milestones Plus Royalties Partnership Leverages the VAC Allogeneic Cancer Immunotherapy Vaccine Platform and Immunomic’s Proprietary Tumor Associated Antigen to Generate a Novel ...
Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing novel cell therapies for unmet medical needs, announced today that updated interim results from a Phase 1/2a study of its lead product candidate, OpRegen ® ...
Penny Stocks Are Risky But Have Far Outperformed Blue-Chips In 2021 There’s no secret that penny stocks are high-risk. But there’s something about these cheap stocks that give a sense of excitement. There are few places where you can buy something for $100 1 day and se...
Arcadia Biosciences RKDA +37% on Q4 results.ProPhase Labs PRPH +31% on VaccTrack acquisition.ClearOne CLRO +19% on Q4 results.Taoping TAOP +17% on share purchase agreement with Genie Global Limited.SPAR Group SGRP +16% on Q4 results.Greenlane ...
Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing novel cell transplants for serious medical conditions, today announced that a patient suffering from adult-onset vitelliform macular dystrophy (AVMD) had recently been t...
Seventy-Five Percent of All Cohort 4 Patients Have Experienced BCVA Increases Visual Acuity Continues to Decline in the Majority of Untreated Eyes No Acute or Delayed Inflammation or Rejection of OpRegen Observed, Even in Patients Treated with a Reduced Immunosuppres...
News, Short Squeeze, Breakout and More Instantly...
Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs, today announced that the Company has been added as a member of the broad-market Russell 3000 ® Index, effective after...
Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs, today announced that the Company’s CEO, Brian M. Culley, will present at the 2024 BIO International Convention , on Tue...
Persons with Lived Experience Session Expanded to Include Michaela & Kyle Devins Clinical Session Expanded to Include Neuralink Preclinical Session Expanded to Include Axonis, Novoron, Sania & Rewire Medical Lineage Cell Therapeutics, Inc. (NYSE America...